Viome announces it has entered into an agreement with Campbell Soup Company (NYSE:CPB) to acquire Habit, a leading personalized nutrition company that takes the guesswork out of eating right. Now operating as one, the two […]
The Pharmabiotic Research Institute (PRI), a non-for-profit pro industry group that assists its members with the development of their Microbiotic Medicinal Products (MMPs) is hosting an ‘/OMICS’ Task Group March 14th in Paris, following Pharmabiotics 2019 Conference […]
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a Japanese dairy product company, today announced new research showing that consumption of its proprietary probiotic Morinaga Bifidobacterium infantis M-63 improved the mental state of victims of the disastrous 2014-2015 […]
4D pharma plc (AIM: DDDD) announces the publication of a paper outlining the mechanism and strong immuno-stimulatory effects of MRx0518. The paper ‘The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant‘ […]
Archer Daniels Midland Company (NYSE: ADM) announced today that it has successfully completed its €1.544 billion acquisition of Neovia, creating a global leader in value-added products and solutions for both production and companion animals. “The […]
Azitra, Inc., a company developing microbiome-based cosmetics and therapeutics to treat skin diseases and conditions, announced that enrollment has been completed for the first human safety study of AZT-04. AZT-04 is the Company’s lead product […]
Microbiome discovery platform company Eagle Genomics announces funding of $3.5M led by the Environmental Technologies Fund (ETF Partners), a European growth fund specialising in promoting sustainability through innovation. The raise will accelerate the development of […]
4D pharma plc (AIM: DDDD) announces the publication of a paper outlining the mechanism and strong immuno-stimulatory effects of MRx0518. The paper ‘The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant‘ […]
Evelo Biosciences, Inc.(Nasdaq: EVLO) (“Evelo”), a biotechnology company developing monoclonal microbials, a new modality of oral biologic medicines, announced that the University of Chicago has dosed the first patient in an investigator-sponsored Phase 2a clinical […]
Second Genome, Inc., a clinical-stage company focused on the development of novel therapeutics identified through microbiome science, today announced that the first patient has been dosed in a Phase 2 clinical trial evaluating SGM-1019 for […]
One month short of its official 145th anniversary, global bioscience company Chr. Hansen is ranked the most sustainable company in the world by Corporate Knights, a specialized Toronto-based media and investment research firm. This was […]